FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma

MLA

Xiaowei Tang, et al. “FANCD2 as a Novel Prognostic Biomarker Correlated with Immune and Drug Therapy in Hepatitis B-Related Hepatocellular Carcinoma.” European Journal of Medical Research, vol. 28, no. 1, Oct. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s40001-023-01411-0.

APA

Xiaowei Tang, Bei Luo, Shu Huang, Jiao Jiang, Yuan Chen, Wensen Ren, Xiaomin Shi, Wei Zhang, Lei Shi, Xiaolin Zhong, & Muhan Lü. (2023). FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. European Journal of Medical Research, 28(1), 1–15. https://doi.org/10.1186/s40001-023-01411-0

Chicago

Xiaowei Tang, Bei Luo, Shu Huang, Jiao Jiang, Yuan Chen, Wensen Ren, Xiaomin Shi, et al. 2023. “FANCD2 as a Novel Prognostic Biomarker Correlated with Immune and Drug Therapy in Hepatitis B-Related Hepatocellular Carcinoma.” European Journal of Medical Research 28 (1): 1–15. doi:10.1186/s40001-023-01411-0.